Healthcare / Medical Care FacilitiesFrankfurt
$2.06
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 12%
FCF escenarios
weak_data · normalized FCF $15.3M · quality 21.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
41/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.1B
P/E
42.7x
↑EV/EBITDA
7.0x
↓ROE
5.9%
↑Gross Margin
81.6%
↑Debt/Equity
4.04
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+23.9%
FCF CAGR
-40.0%
FCF margin
1.0%
FCF / Net income
1.10x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.72B · net income $25.5M · FCF $28.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.72B | $2.72B | $2.21B | $1.80B | $1.43B |
| Net Income | $25.5M | $25.5M | $3.7M | $32.2M | $102.6M |
| EBITDA | $387.6M | $387.6M | $278.0M | $236.3M | $270.8M |
| EPS | 0.05 | 0.05 | 0.01 | 0.06 | 0.19 |
| Gross Margin | 81.6% | 81.6% | 82.4% | 82.7% | 83.6% |
| Operating Margin | 5.6% | 5.6% | 4.3% | 5.5% | 12.4% |
| Net Margin | 0.9% | 0.9% | 0.2% | 1.8% | 7.2% |
| Balance Sheet | |||||
| Debt/Equity | 4.04 | 4.04 | 3.76 | 2.85 | 2.15 |
| Current Ratio | 0.79 | 0.79 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $28.1M | $28.1M | $-36.4M | $15.3M | $130.5M |
| Returns | |||||
| ROE | 5.9% | 5.9% | 0.9% | 7.7% | 30.3% |
| Valuation | |||||
| P/E | 42.72 | 42.72 | — | — | — |
| EV/EBITDA | 7.04 | 7.04 | — | — | — |
| P/B | 2.52 | 2.52 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 22.8% | 22.8% | 23.1% | 25.8% | — |
| EPS Growth | 587.1% | 587.1% | -88.5% | -68.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
55.9%
EPS terminal req.
$0.18
Spread vs growth
531.2%
5Y implied EPS CAGR
35.6%
EPS terminal req.
$0.22
Spread vs growth
551.5%
10Y implied EPS CAGR
22.1%
EPS terminal req.
$0.36
Spread vs growth
565.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+62.6%
Start / end P/E
180.5x → 42.7x
EPS bridge
0.01 → 0.05
Residual
-448.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.